HERBERT F OETTGEN, MD
Osteopathic Medicine at York Ave, New York, NY
License number
New York 093300
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
1275 York Ave, New York, NY 10021
Phone
(646) 227-3275
Personal information
See more information about HERBERT F OETTGEN at radaris.comName
Address
Phone
Wilmington, NY
Professional information
Dr. Herbert Oettgen, New York NY - MD (Doctor of Medicine)
Specialties:
Oncology
Address:
MSKCC
1275 York Ave, New York 10065
(866) 425-8999 (Phone)
1275 York Ave, New York 10065
(866) 425-8999 (Phone)
Languages:
English
Hospitals:
MSKCC
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
1275 York Ave, New York 10065
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Philosophy:
I am a medical oncologist who specializes in the treatment of lung cancer and malignant melanoma. My laboratory research has identified molecular targets for vaccines and monoclonal antibodies on cancer cells. My clinical research has involved testing immunological cancer treatments including vaccines, monoclonal antibodies, and products of the immune system called cytokines.
Education:
Medical School
Universitaet Zu Koeln, Medizinische Fakultat
Graduated: 1950
Universitaet Zu Koeln, Medizinische Fakultat
Graduated: 1950
Herbert F Oettgen, New York NY
Specialties:
Internist
Address:
1275 York Ave, New York, NY 10065
633 3Rd Ave, New York, NY 10017
633 3Rd Ave, New York, NY 10017
Process For The Preparation Of Immunopotentiating Agents From Components Of Yeast Cell Wall Material
US Patent:
4138479, Feb 6, 1979
Filed:
Sep 12, 1977
Appl. No.:
5/832300
Inventors:
Ernst Truscheit - Doenberg, DE
Robert Bierling - Wuppertal, DE
Horst D. Schlumberger - Wuppertal, DE
Herbert F. Oettgen - New York NY
Robert Bierling - Wuppertal, DE
Horst D. Schlumberger - Wuppertal, DE
Herbert F. Oettgen - New York NY
Assignee:
Bayer Aktiengesellschaft
International Classification:
A61K 3900, A61K 3902, A61K 3170
US Classification:
424 88
Abstract:
A water soluble immunopotentiating agent is derived from yeast cell wall material, including mechanically disrupted yeast cell walls, proteolyzed yeast cell wall material and carbohydrate-protein complexes found in yeast cell wall material, through extraction with a water-phenol mixture. The water soluble agent is isolated from the water phase and can be further purified, as through dialysis, to remover low molecular weight components.